ライフサイエンスコーパス: abdominal discomfort

1 cs and some clinical symptom measures (e.g., abdominal discomfort).

2 apy (SBRT), with an index symptom of pain or abdominal discomfort.

3 The most frequent AE was mild abdominal discomfort.

4 rgency, or FI, as well as full resolution of abdominal discomfort.

5 value of fecal calprotectin in patients with abdominal discomfort.

6 l changes (14%), and splenomegaly (36%) with abdominal discomfort.

7 rtment with fever, chills, rigors, and upper abdominal discomfort.

8 ed a hospital admission 2 months earlier for abdominal discomfort.

9 headache (22%), runny or stuffy nose (19%), abdominal discomfort (18%), fatigue (17%), and diarrhea

10 symptom was pain in 34 patients (65.4%), and abdominal discomfort (34.6%) in 18 patients.

11 roup and the FIB-4 > 3.25 group and included abdominal discomfort (4.4% vs. 5.9%), fatigue (4.1% vs.

12 n group and 4 [8%] in the placebo group) and abdominal discomfort (7 [13%] in the metformin group and

13 g a daily symptom diary to determine general abdominal discomfort, abdominal bloating, abdominal pain

14 DeltaVAS of >=15 mm for overall GI symptoms, abdominal discomfort, abdominal pain, bloating, and/or f

15 arian subscales) and neurotoxicity (Ntx) and abdominal discomfort (AD) subscales were used to assess

16 A 10-L paracentesis improved abdominal discomfort and disclosed a transudate, suggest

17 Patients with lower CT blood flow had more abdominal discomfort and immunoglobulin A-antilipopolysa

18 mozygous F508del CF, presents to clinic with abdominal discomfort and intermittent blood in stools.

19 35 years have hepatic cysts, which may cause abdominal discomfort and occasionally require medical or

20 consumption modestly increased postprandial abdominal discomfort and perturbed gut microbiota compos

21 complete SBMs, stool consistency, straining, abdominal discomfort, and bloating.

22 including diarrhea, flatulence, weight loss, abdominal discomfort, and nausea.

23 Irritable bowel syndrome refers to abdominal discomfort associated with altered bowel habit

24 majority of patients also report non-painful abdominal discomfort, associated psychiatric conditions

25 cy, nocturnal diarrhea, FI, and postprandial abdominal discomfort before administration of SBI.

26 complete SBM, stool consistency, straining, abdominal discomfort, bloating, global assessments, and

27 d at normalizing bowel habit alterations and abdominal discomfort, even though some of the most effec

28 In patients with abdominal discomfort, fecal calprotectin is a useful non

29 resolution of diarrhea and absence of severe abdominal discomfort for more than 2 consecutive days in

30 The patient reported upper abdominal discomfort for two months; nausea, vomiting or

31 The evaluation of patients with abdominal discomfort is challenging and patient selectio

32 l gastrointestinal disorder characterized by abdominal discomfort or pain that is accompanied by a di

33 zinc supplementation compared with placebo (abdominal discomfort or pain: 66 [6%] vs 40 [3%], respec

34 increased viscerosomatic referral and lower abdominal discomfort outlasting the experimental stimula

35 d to the emergency department with worsening abdominal discomfort over the past 2-3 months.

36 sophageal discomfort', 'bowel dysfunction', 'abdominal discomfort', 'pelvic floor dysfunction', and '

37 ialysis presented to the emergency room with abdominal discomfort, rectal pain, and blood-tinged stoo

38 ational study, 575 consecutive patients with abdominal discomfort referred for endoscopy to the Depar

39 ts in the thrice-daily arm reported a higher abdominal discomfort score.

40 re associated with heavy menstrual bleeding, abdominal discomfort, subfertility, and a reduced qualit

41 Clinically, it presents with abdominal discomfort, tender hepatomegaly and elevated t

42 , she was cachectic and reported significant abdominal discomfort that kept her from eating well over

43 nactivity, night sweats, itching, bone pain, abdominal discomfort, weight loss, and fevers.

44 Recent vomiting and abdominal discomfort were due to a high-grade stenosis i

45 Diarrhea and abdominal discomfort were the most frequently reported a

46 es of GI discomfort (e.g., nausea, bloating, abdominal discomfort) with mild to severe adverse GI sym